Stocks
HCA Healthcare Financial Statements (HCA) |
||||||||||
| HCA Healthcaresmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 20.02.2020 | 19.02.2021 | 18.02.2022 | 17.02.2023 | 16.02.2024 | 02.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 51 336 | 51 533 | 58 752 | 60 233 | 64 968 | 68 194 | |||
| Operating Income, bln rub | 7 261 | 7 316 | 9 791 | 9 098 | 9 627 | 10 032 | ||||
| EBITDA, bln rub | ? | 9 857 | 10 037 | 12 644 | 12 067 | 12 726 | 13 208 | |||
| Net profit, bln rub | ? | 3 505 | 3 754 | 6 956 | 5 643 | 5 242 | 5 868 | |||
| OCF, bln rub | ? | 7 602 | 9 232 | 8 959 | 8 522 | 9 431 | 10 091 | |||
| CAPEX, bln rub | ? | 4 158 | 2 835 | 3 577 | 4 395 | 4 744 | 4 542 | |||
| FCF, bln rub | ? | 3 444 | 6 397 | 5 382 | 4 127 | 4 687 | 5 549 | |||
| Dividend payout, bln rub | 550.0 | 153.0 | 624.0 | 653.0 | 661.0 | 692.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 15.7% | 4.08% | 8.97% | 11.6% | 12.6% | 11.8% | ||||
| OPEX, bln rub | 35 637 | 35 902 | 39 593 | 41 809 | 45 439 | 39 932 | ||||
| Cost of production, bln rub | 8 481 | 8 369 | 9 481 | 9 371 | 9 902 | 34 559 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 1 824 | 1 584 | 1 566 | 1 741 | 1 938 | 1 998 | ||||
| Assets, bln rub | 45 058 | 47 490 | 50 742 | 52 438 | 56 211 | 56 962 | ||||
| Net Assets, bln rub | ? | -2 808 | 572.0 | -933.0 | -2 767 | -1 774 | -1 615 | |||
| Debt, bln rub | 35 221 | 32 677 | 36 334 | 39 836 | 41 859 | 42 103 | ||||
| Cash, bln rub | 621.0 | 1 793 | 1 451 | 908.0 | 1 022 | 1 284 | ||||
| Net debt, bln rub | 34 600 | 30 884 | 34 883 | 38 928 | 40 837 | 40 819 | ||||
| Ordinary share price, rub | 147.8 | 164.5 | 256.9 | 240.0 | 270.7 | 228.0 | ||||
| Number of ordinary shares, mln | 341.2 | 338.3 | 323.3 | 290.3 | 272.4 | 263.2 | ||||
| Market cap, bln rub | 50 434 | 55 633 | 83 066 | 69 672 | 73 734 | 60 011 | ||||
| EV, bln rub | ? | 85 034 | 86 517 | 117 949 | 108 600 | 114 571 | 100 830 | |||
| Book value, bln rub | -11 077 | -8 006 | -10 473 | -12 420 | -11 719 | -11 582 | ||||
| EPS, rub | ? | 10.3 | 11.1 | 21.5 | 19.4 | 19.2 | 22.3 | |||
| FCF/share, rub | 10.1 | 18.9 | 16.6 | 14.2 | 17.2 | 21.1 | ||||
| BV/share, rub | -32.5 | -23.7 | -32.4 | -42.8 | -43.0 | -44.0 | ||||
| EBITDA margin, % | ? | 19.2% | 19.5% | 21.5% | 20.0% | 19.6% | 19.4% | |||
| Net margin, % | ? | 6.83% | 7.28% | 11.8% | 9.37% | 8.07% | 8.60% | |||
| FCF yield, % | ? | 6.83% | 11.5% | 6.48% | 5.92% | 6.36% | 9.25% | |||
| ROE, % | ? | -124.8% | 656.3% | -745.6% | -203.9% | -295.5% | -363.3% | |||
| ROA, % | ? | 7.78% | 7.90% | 13.7% | 10.8% | 9.33% | 10.3% | |||
| P/E | ? | 14.4 | 14.8 | 11.9 | 12.3 | 14.1 | 10.2 | |||
| P/FCF | 14.6 | 8.70 | 15.4 | 16.9 | 15.7 | 10.8 | ||||
| P/S | ? | 0.98 | 1.08 | 1.41 | 1.16 | 1.13 | 0.88 | |||
| P/BV | ? | -4.55 | -6.95 | -7.93 | -5.61 | -6.29 | -5.18 | |||
| EV/EBITDA | ? | 8.63 | 8.62 | 9.33 | 9.00 | 9.00 | 7.63 | |||
| Debt/EBITDA | 3.51 | 3.08 | 2.76 | 3.23 | 3.21 | 3.09 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 8.10% | 5.50% | 6.09% | 7.30% | 7.30% | 6.66% | ||||
| HCA Healthcare shareholders | ||||||||||
